F1Pharma
R&D solutions for pharmaceutical industry
Unia Europejska
PL
EN
  • About company
    • F1 Pharma
    • Mission and Quality policy
    • Team
    • Management board
    • Supervisory Board
    • Information for shareholders
    • EU funds
    • Manufacturing Authorisation
  • Services offer
    • Pharmaceutical technology
    • Analytics
    • Stability studies
    • Quality assurance
  • News
  • Partners
  • Career
  • Contact
Our mission
Highest quality of provided drug products
Scientific achievements combined with practical experience
Read more
Complex drug
product development
Read more
Strong scientific team
Many years of experience in complementary fields of lifesciences
Read more
High quality standards
We supply high quality, safe products
to meet our customers' requirements at all times
Time and costs efficiency
combined with modern facilities
Pharmaceutical
technology
Analytics
Stability
studies
Quality
assurance

News

15 May

F1 Pharma a silver sponsor of the scientific conference ACCORD 2022

We are pleased to announce that F1 Pharma S.A. is a silver sponsor and a participant of international conference INTERDISCIPLINARY CONFERENCE ON DRUG SCIENCES ACCORD 2022 „Synergy of...
Read more
30 October

Manufacturing authorisation for F1 Pharma S.A.

On 30 October 2019 the Chief Pharmaceutical Inspectorate granted a new Manufacturing Authorisation for F1 Pharma S.A. As a result of the transformation of F1 Pharma into a joint stock company, we submitted a request to the Chief Pharmaceutical Inspectorate for the amendment of our Manufacturing Authorisation.
Read more
02 September

Completion of project co-funded by NCBiR

F1 Pharma successfully completed project granted by the National Center of Research and Development in Fast Track programme fulfilling both scientific and financial targets. We are happy to inform that the project of “The development of innovative forms of mucolytic drugs, suitable for application to children, elderly persons and persons suffering from esophageal dysphagia”, funded by the National Centre for Research and Development (NCBiR), under the R&D Business Projects scheme, has been completed, accepted and financially concluded with the NCBiR.
Read more
Fundusze Europejskie
Unia Europejska
F1Pharma
  • About company
  • Services offer
  • News
  • Partners
  • Career
  • Contact
Copyright by F1Pharma 2023
Web design: Triso.pl